Meta-analysis shows age-based fixed ivermectin dosing could transform MDA campaigns
Ivermectin, one of the two medicines used in our fixed-dose [...]
STOP2030 team at InCORNTD 2025
Colleagues from the STOP2030 consortium attended last week the [...]
Our FDC of albendazole & ivermectin demonstrates safety and superior efficacy in phase 2-3 trial
Researchers from African, Latin American and European organisations have published [...]
WHO Publishes the First Guidelines for Controlling Strongyloides stercoralis
Controlling Strongyloides stercoralis: WHO's recommendations for addressing it as a [...]
ESACIPAC (KEMRI) designated as a WHO Collaborating Centre on NTDs
The Eastern and Southern Africa Centre of International Parasite [...]
STOP2030 welcomes its Scientific & Technical Advisory Board
Our project has taken an important step forward by [...]
Promoting WASH measures to combat NTDs
Every 22nd of March we celebrate World Water [...]
The design of our REALISE study is now complete, and public
At STOP2030 we want to provide a pharmacological tool [...]
Neglected Women’s Diseases: Addressing the Gender Gap in NTDs
We live in a world of inequalities. On [...]
Uniting for progress: STOP2030 kick-starts collaboration in Madrid
The STOP2030 kick-off meeting held on the 6th and 7th [...]
